With the newest DNA sequencing technology starting to reach the market, we're seeing a bit of a bifurcation. Some of the methods can do long reads, covering hundreds of bases, and provide data that's appropriate for assembling a genome that's never been sequenced before. Others produce lots of shorter reads, which can only be aligned to a genome that we know the sequence of already. What good is repeating a completed genome? Po....
Ars Technica
